tradingkey.logo
tradingkey.logo
Suchen

Bioharvest Sciences Inc

BHST
Zur Watchlist hinzufügen
3.040USD
+0.130+4.47%
Trading geöffnet ETKurse um 15 Minuten verzögert
68.91MMarktkapitalisierung
VerlustKGV TTM

mehr Informationen über Bioharvest Sciences Inc Unternehmen

BioHarvest Sciences Inc. is a botanical synthesis company. The Company leverages its patented technology process to grow plant-based molecules, without the need to grow the underlying plant. It is leveraging its botanical synthesis technology to develop the next generation of science-based and clinically proven therapeutic solutions within two business verticals: as a contract development and production organization on behalf of customers seeking complex molecules, and as a creator of nutraceutical health and wellness products, which include dietary supplements. Its segments include Nutraceuticals and Pharmaceuticals. VINIA is a red grape cell-based supplement, which is a commercial nutraceutical product derived from the Botanical Synthesis platform and is clinically proven to improve blood flow, which enhances physical energy and mental alertness. VINIA contains multiple polyphenols, including Piceid Resveratrol, which is 25x more soluble in water than regular resveratrol.

Bioharvest Sciences Inc Informationen

BörsenkürzelBHST
Name des UnternehmensBioharvest Sciences Inc
IPO-datumAug 05, 2015
CEOSobel (Ilan)
Anzahl der mitarbeiter- -
WertpapierartOrdinary Share
GeschäftsjahresendeAug 05
Addresse1140 - 625 Howe Street
StadtVANCOUVER
BörseNASDAQ OMX - NASDAQ BASIC
LandCanada
PostleitzahlV6C 2T6
Telefon16046221186
Websitehttps://bioharvest.com/about/
BörsenkürzelBHST
IPO-datumAug 05, 2015
CEOSobel (Ilan)

Führungskräfte von Bioharvest Sciences Inc

Name
Name/Position
Position
Aktienbesitz
Veränderung
Mr. Vivien Rakib
Mr. Vivien Rakib
Independent Director
Independent Director
3.04M
--
Mr. Ilan Sobel
Mr. Ilan Sobel
Chief Executive Officer
Chief Executive Officer
216.88K
--
Mr. David K. Ryan
Mr. David K. Ryan
Vice President - Investor Relations, Secretary
Vice President - Investor Relations, Secretary
39.01K
--
Mr. Yoheved (Yochi) Hagay
Mr. Yoheved (Yochi) Hagay
Chief Technology Officer
Chief Technology Officer
31.70K
--
Ms. Anne Binder
Ms. Anne Binder
Independent Director
Independent Director
17.71K
--
Ms. Bar (Moreh) Dichter
Ms. Bar (Moreh) Dichter
Chief Financial Officer
Chief Financial Officer
1.52K
--
Dr. Ilana Belzer
Dr. Ilana Belzer
Chief Operating Officer
Chief Operating Officer
546.00
--
Mr. Zaki Rakib
Mr. Zaki Rakib
Chairman of the Board, President
Chairman of the Board, President
--
--
Mr. John (Jake) Fiddick
Mr. John (Jake) Fiddick
Independent Director
Independent Director
--
--
Mr. David Tsur
Mr. David Tsur
Independent Director
Independent Director
--
--
Mehr Anzeigen
Name
Name/Position
Position
Aktienbesitz
Veränderung
Mr. Vivien Rakib
Mr. Vivien Rakib
Independent Director
Independent Director
3.04M
--
Mr. Ilan Sobel
Mr. Ilan Sobel
Chief Executive Officer
Chief Executive Officer
216.88K
--
Mr. David K. Ryan
Mr. David K. Ryan
Vice President - Investor Relations, Secretary
Vice President - Investor Relations, Secretary
39.01K
--
Mr. Yoheved (Yochi) Hagay
Mr. Yoheved (Yochi) Hagay
Chief Technology Officer
Chief Technology Officer
31.70K
--
Ms. Anne Binder
Ms. Anne Binder
Independent Director
Independent Director
17.71K
--
Ms. Bar (Moreh) Dichter
Ms. Bar (Moreh) Dichter
Chief Financial Officer
Chief Financial Officer
1.52K
--

Häufig gestellte Fragen

Wer sind die fünf größten Anteilseigner von Bioharvest Sciences Inc?

Die fünf größten Anteilseigner von Bioharvest Sciences Inc sind: Mr. Vivien Rakib

Wie viele Institutionen halten Anteile an Bioharvest Sciences Inc (BHST)?

Mit Stand vom 2026Q1 halten 27 Institutionen Anteile an Bioharvest Sciences Inc, mit einem Gesamtmarktwert von etwa 1.80M, was 8.94% der Gesamtanteile entspricht. Im Vergleich zum 2025Q4 ist der institutionelle Aktienbesitz um 1653148.00 gestiegen.